Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Chemomab Therapeutics Ltd. - American Depositary Shares
(NQ:
CMMB
)
1.760
-0.120 (-6.39%)
Streaming Delayed Price
Updated: 11:45 AM EST, Dec 26, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Chemomab Therapeutics Ltd. - American Depositary Shares
< Previous
1
2
3
4
Next >
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
August 19, 2025
Via
Benzinga
Chemomab Therapeutics' Touts Positive Data From Experimental Drug For Chronic Liver Disease
↗
March 27, 2025
Chemomab's OLE study of nebokitug in PSC patients confirmed safety and showed improvements in liver stiffness, fibrosis biomarkers, and cholestasis markers.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
March 25, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
October 15, 2024
Via
Benzinga
Earnings Scheduled For November 14, 2024
↗
November 14, 2024
Via
Benzinga
Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
September 03, 2024
Via
Benzinga
CMMB Stock Earnings: Chemomab Therapeutics Reported Results for Q2 2024
↗
August 21, 2024
Chemomab Therapeutics just reported results for the second quarter of 2024.
Via
InvestorPlace
Chemomab Therapeutics Reveals Data From Mid-Stage Study For Liver Disease Candidate, Stock Plunges On Capital Raise
↗
July 25, 2024
Chemomab Therapeutics reports successful Phase 2 SPRING trial results for CM-101 in primary sclerosing cholangitis, showing safety and efficacy. Key findings include significant improvements in liver...
Via
Benzinga
CMMB Stock Earnings: Chemomab Therapeutics Reported Results for Q1 2024
↗
May 09, 2024
Chemomab Therapeutics just reported results for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
↗
May 06, 2024
Via
Benzinga
CMMB Stock Earnings: Chemomab Therapeutics Reported Results for Q4 2023
↗
March 07, 2024
Chemomab Therapeutics just reported results for the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
February 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
February 21, 2024
Via
Benzinga
Earnings Scheduled For March 7, 2024
↗
March 07, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
February 20, 2024
Via
Benzinga
What's Going On With Fibro-Inflammatory Disease Focused Chemomab Therapeutics On Tuesday?
↗
February 20, 2024
Chemomab Therapeutics' CM-101 granted new patents in Brazil and Israel, currently in Phase 2 SPRING trial for primary sclerosing cholangitis. Topline data readout expected by mid-2024.
Via
Benzinga
Topics
Intellectual Property
Why M.D.C. Holdings Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
↗
January 18, 2024
Shares of M.D.C. Holdings, Inc. (NYSE: MDC) rose sharply in today’s pre-market trading. Sekisui House, Ltd. and M.D.C. Holdings announced an agreement pursuant to which a wholly-owned subsidiary of...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
January 18, 2024
Pre-market stock movers are a hot topic this morning as we check out all of the winners and losers worth keeping tabs on for Thursday!
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
↗
November 29, 2023
Pre-market stock movers are a good way to start the day as we dive into the biggest news worth checking out on Wednesday morning!
Via
InvestorPlace
Why Children's Place Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
November 16, 2023
Shares of The Children's Place, Inc. (NASDAQ: PLCE) moved lower during Thursday’s session following weak quarterly earnings.
Via
Benzinga
Why Palo Alto Networks Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarket
↗
November 16, 2023
Shares of Palo Alto Networks, Inc. (NASDAQ: PANW) fell in pre-market trading after reporting first-quarter results.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
November 16, 2023
It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Thursday!
Via
InvestorPlace
Crude Oil Falls 2%; TJX Issues Weak Earnings Outlook
↗
November 15, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 150 points on Wednesday. The Dow traded up 0.46% to 34,989.30 while the NASDAQ rose 0.16% to 14,116.28. The S&P...
Via
Benzinga
Topics
Stocks
US Stocks Gain; Producer Prices Fall In October
↗
November 15, 2023
U.S. stocks traded higher this morning, with the Dow Jones gaining around 90 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.27% to 34,922.07 while the NASDAQ rose...
Via
Benzinga
Topics
Stocks
Why is Liver Disease Focused Chemomab Stock Trading Higher Today?
↗
November 15, 2023
Chemomab Therapeutics Ltd (NASDAQ: CMMB) shares are trading higher after the FDA granted CM-101 Fast Track designation for adult patients of primary sclerosing cholangitis (PSC),
Via
Benzinga
Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
November 15, 2023
Shares of Shapeways Holdings, Inc. (NASDAQ: SHPW) tumbled during Wednesday’s session following downbeat results.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
November 15, 2023
Via
Benzinga
What's Going On With Chemomab Therapeutics Stock Today
↗
June 21, 2023
Chemomab Therapeutics Ltd (NASDAQ: CMMB) reported topline results from secondary Phase 2a liver fibrosis trial analyses assessing CM-101 in patients with
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023
↗
October 06, 2023
Via
Benzinga
Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
June 22, 2023
Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the company announced acquisition of Spyre Therapeutics and concurrent oversubscribed $210 million private...
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
